0QLR Novartis AG Novartis announces NEJM publication of Phase III ASCLEPIOS trials demonstrating superior efficacy of ofatumumab in patients with relapsing multiple sclerosis
RKMD Rostelecom PJSC ADR Rostelecom announces its IFRS financial and operating results for the second quarter and half year 2020